FSD Pharma Inc. announced that it entered into agreement with Applied Science and Performance Institute (ASPI) in Tampa, Florida, on April 24, 2024 to conduct "A Randomized, Double-Blind, Placebo-Controlled Crossover Study to Assess the Safety and Efficacy of unbuzzd? in Healthy volunteers in an Induced State of Alcohol Intoxication (METAL-2 TRIAL)". unbuzzd?

is a unique dietary supplement with natural ingredients, vitamins and GRAS (Generally Recognized as Safe) ingredients that potentially enhances cognition, replenishes cofactors needed for alcohol metabolism, and may accelerate alcohol metabolism in the body. In the METAL-2 trial, the ability of unbuzzd? to reverse the effects of acute alcohol intoxication will be compared to a placebo in a crossover design with thirty healthy volunteers randomized in the trial.

FSD Pharma licensed this technology to Celly Nutrition Corp. for the recreational sale of unbuzzd?.